Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07207876 · ClinicalTrials.gov registry record
Study of Ceftriaxone and Benzathine Penicillin G During Pregnancy
A clinical trial of Pregnancy, sponsored by International Maternal Pediatric Adolescent AIDS Clinical Trials Group.
- Recruiting
- Registry status
- 110
- Enrollment target
- 9
- Study locations
NCT07207876: Recruiting study of Pregnancy, sponsored by International Maternal Pediatric Adolescent AIDS Clinical Trials Group.
NCT07207876 is a study of Pregnancy that is actively recruiting participants, run by International Maternal Pediatric Adolescent AIDS Clinical Trials Group. The registered enrollment target is 110 participants, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (87% lower). The trial reports 9 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07207876, a study of Pregnancy, is actively recruiting participants, sponsored by International Maternal Pediatric Adolescent AIDS Clinical Trials Group.
- RECRUITING
- Registry status
- 110 participants
- Enrollment target
- 9
- Study locations
Study Summary
IMPAACT 2044 is a study to characterize the pharmacokinetics (PK) and safety of ceftriaxone and benzathine penicillin G during pregnancy. Up to 78 pregnant women receiving (1) ceftriaxone for indications other than syphilis or (2) benzathine penicillin G for treatment of syphilis from non-study clinical care providers will be enrolled at study sites located in the United States. Approximately 22 infants of pregnant participants receiving benzathine penicillin G will also be enrolled.
Primary Outcome
Arm 1A
Conditions Studied
Interventions
- DRUG Ceftriaxon
- DRUG Benzathine penicillin G
Study Locations (9)
New York
- Site 5040, SUNY Stony Brook NICHD CRS - Stony Brook
- Site 5114, Bronx-Lebanon Hospital Center NICHD CRS - The Bronx
- Site 5013, Jacobi Med. Ctr. Bronx NICHD CRS - The Bronx
California
- Site 5048, USC - Maternal Child Adolescent/Adult Center - Los Angeles
- Site 5112, David Geffen School of Medicine at UCLA NICHD CRS - Los Angeles
Illinois
- Site 5083, Rush Univ. Cook County Hosp. Chicago NICHD CRS - Chicago
- Site 4001, Lurie Children's Hospital of Chicago (LCH) CRS - Chicago
Texas
- Site 5128, Baylor College of Medicine/Texas Children's Hospital NICHD CRS - Houston
Other
- Site 5129, IMPAACT/Gamma Project/UPR Pediatric HIV/AIDS Research CRS - San Juan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2026-02-16 |
| Est. Completion | 2027-04-30 |
What NCT07207876 shows while recruiting
NCT07207876 is an observational study that tracks outcomes without assigning an intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 872-participant average among 191 other Pregnancy trials with a reported enrollment target (87% lower).
The record links to 1 condition, with Pregnancy appearing as the primary indexed condition, and to 2 interventions - of which Ceftriaxon is the first listed.
NCT07207876 lists 9 locations in 5 states (New York, California, Illinois).
Frequently Asked Questions
What is clinical trial NCT07207876 about?
NCT07207876 is a clinical study titled "Study of Ceftriaxone and Benzathine Penicillin G During Pregnancy". IMPAACT 2044 is a study to characterize the pharmacokinetics (PK) and safety of ceftriaxone and benzathine penicillin G during pregnancy. Up to 78 pregnant women receiving (1) ceftriaxone for indications other than syphilis or (2) benzathine penicillin G for treatment of syphilis from non-study clin...
What is the current status of trial NCT07207876?
This trial is currently recruiting. The enrollment target is 110 participants. The study started on 2026-02-16. Estimated completion is 2027-04-30.
What conditions does trial NCT07207876 study?
This clinical trial studies the following conditions: Pregnancy.
What interventions are being tested in trial NCT07207876?
The interventions under investigation include: Ceftriaxon (DRUG), Benzathine penicillin G (DRUG).
Who is sponsoring clinical trial NCT07207876?
This trial is sponsored by International Maternal Pediatric Adolescent AIDS Clinical Trials Group, which has 17 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07207876 being conducted?
This trial has 9 study locations across California, Illinois, New York, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Pregnancy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07207876's enrollment target sits among peer trials
110 114th of 191 higher than 78 of 191 other Pregnancy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Pregnancy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project
RECRUITING
-
CGM Adherence Compared to Finger-stick Glucose Monitoring in Pregnancies With Type 2 Pregestational Diabetes
RECRUITING · NA
-
Healthy Start: Exploring the Fuel-mediated Programming of Neonatal Growth
RECRUITING
-
Cocooned Moms Study
RECRUITING · NA
-
Retinal Vascular Changes During Pregnancy
RECRUITING
-
CGM for Management of Type 2 Diabetes in Pregnancy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI